This report aims to provide detailed insights into the global cartilage
repair market. It provides valuable information on the type, procedure,
application, and region in the market. Furthermore, the information for these
segments, by region, is also presented in this report. Leading players in the
market are profiled to study their product offerings and understand the
strategies undertaken by them to be competitive in this market.
Expected Revenue Growth Analysis:
The Cartilage Regeneration Market is projected to reach USD 1,603 million by 2025
from USD 787 million in
2020, at a CAGR of 15.3% during the forecast period.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=37493272
Key Factors Driving Market Growth:
The growth of cartilage repair market is primarily driven by the increasing
incidence of osteoarthritis and increasing funding and investments for research
in this field.
The cell-based segment accounted for the largest share of the treatment
modality segment in the cartilage repair market in 2019.
Based on the treatment modality, the cartilage regeneration market is
segmented into cell-based and non-cell-based approaches. The non-cell-based
segment is divided into tissue scaffolds and cell-free composites. In 2019, the
cell-based segment accounted for the largest share of the cartilage
regeneration industry. The large share of this segment can be attributed to
technological advancements in stem cell-based therapies for cartilage repair
and chondrocyte implantation products.
Driver: Increasing Incidence of Osteoarthritis:
Over the years, the incidence of osteoarthritis
has increased across the globe. According to a study by the University of North
Carolina, around 1 million knee and hip replacement procedures are conducted
every year in the US. The economic burden of osteoarthritis in the US is ~136.8
billion annually. As per the Arthritis Foundation in 2019, degenerative joint
diseases such as osteoarthritis will affect more than 130 million patients
worldwide by 2050.
Some of the most commonly used treatments for osteoarthritis are autologous
chondrocyte implantation and Scaffolds implants Thus, the increasing incidence
of osteoarthritis is expected to drive the demand for cartilage repair and
regeneration products.
The Asia Pacific region
is the fastest growing region of the cartilage repair market in 2019.
The Asia Pacific region
is estimated to grow at the highest CAGR in the cartilage regeneration market
during the forecast period, this is mainly due to the rising geriatric
population and the subsequent increase in the incidence of various disorders
and injuries. Recent developments in tissue engineering and stem cell therapy
will further fuel market growth.
Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=37493272
Prominent players in the cartilage regeneration market are Smith & Nephew
plc (UK), DePuy Synthes (US), Zimmer Biomet (US), CONMED Corporation (US),
Stryker Corporation (US), and Vericel Corporation (US).
Extensive primary research was conducted after acquiring basic knowledge about
the global cartilage regeneration market scenario through secondary research.
Several primary interviews were conducted with market experts from both the
demand (such as personnel from the pharmaceutical and biopharmaceutical
industry) and supply sides (such as C-level and D-level executives, product
managers, marketing and sales managers of key manufacturers, and distributors)
across four major regions—North America, Europe, Asia Pacific, and the Rest of
the World. Approximately 80% and 20% of primary interviews were conducted with
supply-side and demand-side participants, respectively.
